Cargando…
GSTM1 and GSTT1 polymorphisms contribute to renal cell carcinoma risk: evidence from an updated meta-analysis
Emerging evidences suggest that GSTM1 and GSTT1 are involved in the detoxification of carcinogens, and polymorphisms in this gene that result in a loss of enzyme activity may increase the risk of renal cell carcinoma (RCC). Thus, to evaluate the association of GSTM1 and GSTT1 polymorphisms and RCC,...
Autores principales: | Huang, Wentao, Shi, Hua, Hou, Qi, Mo, Zu, Xie, Xiangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677290/ https://www.ncbi.nlm.nih.gov/pubmed/26656529 http://dx.doi.org/10.1038/srep17971 |
Ejemplares similares
-
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis
por: Yu, Cui, et al.
Publicado: (2016) -
Cancer Risk and GSTM1 and GSTT1 Polymorphisms
por: Cetta, Francesco, et al.
Publicado: (2009) -
GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis
por: Zhuo, Xianlu, et al.
Publicado: (2009) -
Contribution of GSTM1, GSTT1, and MTHFR polymorphisms to end-stage renal disease of unknown etiology in Mexicans
por: Gutiérrez-Amavizca, B. E., et al.
Publicado: (2013) -
GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population
por: Cho, Hyun-Jung, et al.
Publicado: (2005)